Right to Try Laws and the FDA - By Dr Nicola Davies

Right to Try laws give terminally ill patients access to therapies that have passed Phase I testing but have not achieved US Food and Drug Administration approval. The FDA’s current program, expanded access, already gives these patients access to experimental drugs, but Right to Try laws expedite the process and reduce the FDA’s role in it, comments Dr Nicola Davies in her monthly FDA blog for The Pharma Letter.

38 out of 50 US states have passed various versions of Right to Try laws, and President Donald Trump has voiced support for the federal Right to Try bill passed by the Senate in 2017. Despite wide public support for the federal bill, many, including the FDA, oppose it.

Thalidomide: The Drug that Started It All